413 related articles for article (PubMed ID: 19751371)
1. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
3. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
Elkind AH; MacGregor EA
Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
[TBL] [Abstract][Full Text] [Related]
4. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
Brandes JL; Poole Ac; Kallela M; Schreiber CP; MacGregor EA; Silberstein SD; Tobin J; Shaw R
Cephalalgia; 2009 Nov; 29(11):1133-48. PubMed ID: 19811503
[TBL] [Abstract][Full Text] [Related]
5. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
Spierings EL; Keywood C
Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958
[TBL] [Abstract][Full Text] [Related]
6. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
Wade A; Pawsey S; Whale H; Boyce M; Warrington S
Clin Drug Investig; 2009; 29(5):325-37. PubMed ID: 19366274
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
MacGregor EA; Pawsey SP; Campbell JC; Hu X
Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
12. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
Cady RK; Banks J; Jones BA; Campbell J
Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
[TBL] [Abstract][Full Text] [Related]
13. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
[TBL] [Abstract][Full Text] [Related]
14. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
17. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Silberstein SD; Elkind AH; Schreiber C; Keywood C
Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
[TBL] [Abstract][Full Text] [Related]
19. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
